David Cetlin

David Cetlin is the Founder and former CEO of MockV Solutions. He joined Cygnus Technologies in 2020, after Maravai acquired MockV Solutions. As Senior Director, Research and Development, at Cygnus, he is continuing the work begun at MockV Solutions by leading the R&D efforts to develop and commercialize a series on non-infectious viral clearance prediction kits for the downstream bioprocess industry. Prior to MockV, David worked as a Bioprocess Scientist for Human Genome Sciences (now part of GlaxoSmithKline) developing, optimizing and validating purification strategies for monoclonal antibody therapies and transferring these strategies to large scale production facilities. David holds an M.S. in Biotechnology from Johns Hopkins University and a B.S. in Cellular, Molecular Biology and Genetics from the University of Maryland.